Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Plant Biol (Stuttg) ; 18(5): 785-96, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27061772

ABSTRACT

In trees, the interplay between reduced carbon assimilation and the inability to transport carbohydrates to the sites of demand under drought might be one of the mechanisms leading to carbon starvation. However, we largely lack knowledge on how drought effects on new assimilate allocation differ between species with different drought sensitivities and how these effects are modified by interspecific competition. We assessed the fate of (13) C labelled assimilates in above- and belowground plant organs and in root/rhizosphere respired CO2 in saplings of drought-tolerant Norway maple (Acer platanoides) and drought-sensitive European beech (Fagus sylvatica) exposed to moderate drought, either in mono- or mixed culture. While drought reduced stomatal conductance and photosynthesis rates in both species, both maintained assimilate transport belowground. Beech even allocated more new assimilate to the roots under moderate drought compared to non-limited water supply conditions, and this pattern was even more pronounced under interspecific competition. Even though maple was a superior competitor compared to beech under non-limited soil water conditions, as indicated by the changes in above- and belowground biomass of both species in the interspecific competition treatments, we can state that beech was still able to efficiently allocate new assimilate belowground under combined drought and interspecific competition. This might be seen as a strategy to maintain root osmotic potential and to prioritise root functioning. Our results thus show that beech tolerates moderate drought stress plus competition without losing its ability to supply belowground tissues. It remains to be explored in future work if this strategy is also valid during long-term drought exposure.


Subject(s)
Carbon Dioxide/metabolism , Fagus/physiology , Photosynthesis/physiology , Stress, Physiological , Biological Transport , Biomass , Carbon/metabolism , Carbon Isotopes/analysis , Cell Respiration , Droughts , Phloem/physiology , Plant Leaves/physiology , Plant Roots/physiology , Soil , Trees , Water/physiology
2.
New Phytol ; 190(3): 750-9, 2011 May.
Article in English | MEDLINE | ID: mdl-21261625

ABSTRACT

• Severe drought may increase physiological stress on long-lived woody vegetation, occasionally leading to mortality of overstory trees. Little is known about the factors determining tree survival and subsequent recovery after drought. • We used structural equation modeling to analyse the recovery of Scots pine (Pinus sylvestris) trees 4 yr after an extreme drought episode occurred in 2004-2005 in north-east Spain. Measured variables included the amount of green foliage, carbon reserves in the stem, mistletoe (Viscum album) infection, needle physiological performance and stem radial growth before, during and after the drought event. • The amount of green leaves and the levels of carbon reserves were related to the impact of drought on radial growth, and mutually correlated. However, our most likely path model indicated that current depletion of carbon reserves was a result of reduced photosynthetic tissue. This relationship potentially constitutes a feedback limiting tree recovery. In addition, mistletoe infection reduced leaf nitrogen content, negatively affecting growth. Finally, successive surveys in 2009-2010 showed a direct association between carbon reserves depletion and drought-induced mortality. • Severe drought events may induce long-term physiological disorders associated with canopy defoliation and depletion of carbon reserves, leading to prolonged recovery of surviving individuals and, eventually, to delayed tree death.


Subject(s)
Carbon/metabolism , Droughts , Pinus sylvestris/growth & development , Pinus sylvestris/metabolism , Plant Leaves/growth & development , Regeneration/physiology , Carbohydrates/analysis , Models, Biological , Pinus sylvestris/physiology , Plant Leaves/metabolism , Plant Stems/metabolism
3.
G Ital Med Lav Ergon ; 29(3 Suppl): 529-31, 2007.
Article in Italian | MEDLINE | ID: mdl-18409814

ABSTRACT

Matrix metalloproteinases belong to a growing family of proteases controlled by specific tissue inhibitors, involved in tissutal flogosis, wound healing, cancer invasion and metastasis. We developed an in vitro model to screen for potential toxic compounds in professional exposure. Human keratinocytes (HaCat) were used as target cells while matrix metalloproteinases (MMP) were selected as responders, developing and in vitro model of allergic dermatitis. The chemical agents: potassium dichromate and nickel sulphate as positive teste, because represent the main etiological agents of allergic dermatitis. Nickel contact at very low concentrations (10(-5), 10(-6) M) induced upregulation of MMP-2 and IL-8 mRNA production; chromium contact at very low concentrations killed all cells. Actually, our in vitro research is based on analysis of cytotoxic effects of xenobiotics on human lung fibroblasts; simultaneously we verified serum increasing in vivo of MMP-9, determinated in workers serum, exposed to anesthetic gas (fluorane). In only six exposed workers we observed MMP9 increasing over than normal range. Actually, we are continuing our research on a more representative sample.


Subject(s)
Dermatitis, Contact/etiology , Dermatitis, Occupational/etiology , Matrix Metalloproteinases/physiology , Nickel/toxicity , Occupational Exposure/adverse effects , Potassium Dichromate/toxicity , Cells, Cultured , Dose-Response Relationship, Drug , Humans , Keratinocytes
4.
J Neural Transm (Vienna) ; 110(3): 239-51, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12658373

ABSTRACT

The efficacy and tolerability of entacapone was investigated in a randomized, double-blind, placebo-controlled, 3-month study of 162 patients with Parkinson's disease (PD) treated with levodopa and a dopamine agonist and experiencing wearing-off motor fluctuations. Patients were randomized in a 3 : 2 ratio to entacapone 200 mg or placebo, administered with each dose of levodopa. Efficacy was judged on the improvement of "on" and "off" time while awake (Patient Diary and UPDRS part IV Item 39), Investigators' Global Assessment, the SF-36 Health Survey, and changes in levodopa dosages. Patients were monitored for adverse events, laboratory safety and vital signs throughout the study. Improvements in "on" time as assessed using patient diary data showed a trend in favour of entacapone, however these did not reach statistical significance. "Off" time while awake (UPDRS part IV Item 39) showed an improvement of at least one category in 36% of entacapone-treated patients, compared with 22% in the control group (p = 0.0038). The proportion of patients showing an improvement at the Investigators' Global Assessment was significantly higher (p = 0.0006) in the entacapone-treated group of patients. Also, the proportion of patients with a reduction in their daily levodopa dose was significantly higher (p = 0.02) in the entacapone group (28%) compared with placebo (13%). As expected, the most frequent adverse events were dopamine-mediated (dyskinesia: entacapone 31% versus placebo 13%), and harmless urinary discoloration. The modest increase in dyskinesias could be readily managed by levodopa down-adjustment, and, at study end there was no significant difference for the UPDRS "overall dyskinesia score" between entacapone and placebo. In conclusion, although the primary efficacy variable did not reach statistical significance, the present results demonstrate that entacapone provides additional antiparkinsonian benefits to levodopa therapy and is well tolerated in levodopa-treated PD patients experiencing wearing-off motor fluctuations despite adjunct dopamine agonist therapy.


Subject(s)
Catechols/therapeutic use , Dopamine Agonists/therapeutic use , Levodopa/therapeutic use , Parkinson Disease/drug therapy , Aged , Catechols/adverse effects , Double-Blind Method , Drug Therapy, Combination , Female , Humans , Male , Middle Aged , Nitriles , Parkinson Disease/physiopathology , Parkinson Disease/psychology , Prospective Studies
5.
Rev Neurol ; 27(160): 951-5, 1998 Dec.
Article in Spanish | MEDLINE | ID: mdl-9951011

ABSTRACT

INTRODUCTION: Different studies have shown that aspirin (AAS), in low doses, may lead to a considerable frequency of hemorrhagic complications when used in the long term. OBJECTIVE: We compare the long-term occurrence of hemorrhagic complications with low doses of AAS and high doses of triflusal. PATIENTS AND METHODS: Our series included 106 patients who took 900 mg triflusal per day (300 mg 3 times per day) and 111 who took AAS (330 mg/day once daily). The former were followed up for an average period of 48.3 months (20-94) and the latter for 46.3 months (2-84). The average follow-up period for the study was 47.3 months. The presence of hemorrhagic complications was evaluated, as was their frequency and follow-up curve. RESULTS: Compared with AAS, triflusal led to a 76% reduction in risk of hemorrhagic complications (2.8% against 10.8%; OR 0.24; IC 0.06-0.94). There was a slightly increased incidence of hemorrhages in the women's group. There were more hemorrhages than gastrointestinal hemorrhages (4.5% against 0.9%) and intracranial hemorrhages (1.8%-0.9%). The follow-up curve showed significant differences in the form of an increased risk of hemorrhagic complications with AAS. CONCLUSIONS: The risk of hemorrhage with AAS depended on the period of follow-up, in a similar manner to with oral anticoagulant agents, in patients with prophylaxis of cerebral infarct. On the other hand, this did not occur with triflusal, with which the risk was homogeneous and lower in the long term.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Aspirin/adverse effects , Hemorrhage/chemically induced , Hemorrhage/epidemiology , Platelet Aggregation Inhibitors/adverse effects , Salicylates/adverse effects , Adult , Cerebral Infarction/prevention & control , Female , Follow-Up Studies , Humans , Male , Middle Aged , Risk Factors , Sex Factors , Time Factors
6.
Rev. chil. anat ; 16(1): 75-82, 1998. tab
Article in Spanish | LILACS | ID: lil-242635

ABSTRACT

Habitualmente las cinturas se estudian en forma separada junto al miembro correspondiente. Los músculos asociados a ellas se reunen en base a un criterio exclusivamente topográfico, resultando los siguientes grupos; músculos del dorso, del cuello, del tórax y del miembro pelviano. Para el miembro torácico se los trata como músculos comunes del miembro, sin tener en cuenta su inserción ni su intervación. En este trabajo se establecen los criterios de homotipia entre ambas cinturas y se proponen pautas para homologar los músculos que unen los miembros torácicos y pelvianos con el esqueleto axial. Para ello, se recurre a su clasificación en extrínsecos e intrínsecos, en base a su origen embriológico, inserción e inervación


Subject(s)
Animals , Dogs , Arm/innervation , Pelvis/innervation , Animals, Domestic/anatomy & histology , Equidae/anatomy & histology , Scapula/innervation , Muscle, Skeletal/anatomy & histology
7.
Rev Neurol ; 23(122): 743-8, 1995.
Article in Spanish | MEDLINE | ID: mdl-7497231

ABSTRACT

Throughout the many studies carried out on patients suffering from migraine, we find that a series of diseases or abnormalities with cardiovascular etiologies may be associated with the risk of migraine. In some studies published so far there is a greater prevalence of distinct cardiovascular diseases among those patients suffering from migraine. The shortage of case-control studies which might otherwise definitely establish a relationship between migraine and other cardiovascular diseases leads us to cautiously interpret the meaning of these associations. We studied family and personal history of cardiovascular disease in a group of patients with migraine, and we carried out a case-control study to try to establish the greatest risk of suffering from these diseases by our patients. We found that family antecedents of migraine with the next of kin was a risk factor for getting migraine and that Raynaud's disease was associated with a greater risk of suffering with this pathology.


Subject(s)
Cardiovascular Diseases/complications , Cardiovascular Diseases/physiopathology , Migraine Disorders/epidemiology , Migraine Disorders/etiology , Adult , Cardiovascular Diseases/genetics , Case-Control Studies , Female , Humans , Hypertension/complications , Hypertension/physiopathology , Incidence , Male , Prevalence , Raynaud Disease/complications , Raynaud Disease/physiopathology
8.
Rev Neurol ; 23(122): 773-8, 1995.
Article in Spanish | MEDLINE | ID: mdl-7497238

ABSTRACT

Migraine headache is a common, recurrent and often incapacitating disorder resulting in a substantial loss of work days and productivity, significant consumption of medicines, and considerable economic cost. We performed this study in order to determine the characteristic features of migrainous patients with regular or frequent intake of ergotamine preparations and non steroidal anti-inflammatory drugs (NSAIDs) and the existence of significant differences between both groups. 186 patients were included in the study, 36.6% suffering from migraine without aura and 63.4% from migraine with aura. 24.7% were males and 75.3% females. Mean age of the sample was 35.6 +/- 12.9 years. With regard to medication used for immediate relief of headache, 74.7% patients reported an intake of analgesics and 25.3% ergotamine preparations. In patients with analgesic intake the mean age was significantly lower than in patients with ergotamine for treatment of migraine. When clinic features of these two headache groups were examined, the duration of migraine attacks in the analgesic group was significantly higher (p = 0.0014) than in the ergotamine group, and the severity of migraine was lower (p < 0.05) than in this group. Among associated symptoms, nausea and vomiting were significantly less frequent (p = 0.024) in the analgesic group than in the group of patients with ergotamine intake.


Subject(s)
Ergotamines/administration & dosage , Ergotamines/therapeutic use , Migraine Disorders/drug therapy , Vasoconstrictor Agents/administration & dosage , Vasoconstrictor Agents/therapeutic use , Adult , Female , Humans , Male , Middle Aged , Migraine Disorders/complications , Nausea/complications , Severity of Illness Index , Sex Factors , Vomiting/complications
9.
Rev Neurol ; 23(122): 784-8, 1995.
Article in Spanish | MEDLINE | ID: mdl-7497240

ABSTRACT

OBJECTIVES: To establish the role of the age on quality of life of a group of normotensive patients, older than 65 years with vertebrobasilar ischemia, treated with nicardipine. To evaluate the influence of the Nicardipine side effects on the quality of life of these patients within general practice prescription limits. METHOD: An epidemiological cohort study was performed during six months, in several Basic Health Areas distributed all round Spain. Nottingham Health Profile (NHP) was used to evaluate quality of life and was applied at the beginning and at the end of the study. Nicardipine side effects were collected in every evaluation. RESULTS: 838 patients were included in the study, mean age 72.4 +/- 6.8 years, 337 (40.2%) were males and 501 (59.8%) females. When we compared quality of life according to the age, no significant differences were obtained (RR = 0.89; CI 95% 0.77-1.30). NHP global score +/- SD was initially 36.5 +/- 22.8 and 24.5 +/- 19.1 at the end of the study, this result was statistically significant (p < 0.001), which means a percentage of improvement of 33%. These differences were also significant in every NHP area. Side effects were not frequent and with no correlation with quality of life of patients (p = ns). CONCLUSIONS: Our data show that neither the age nor side effects due to nicardipine have influence on quality of life of normotensive patients, older than 65 years with vertebrovascular ischemia, treated with nicardipine. Quality of life assessment can be an useful tool for therapeutical evaluation in these patients.


Subject(s)
Brain Ischemia/drug therapy , Brain Ischemia/physiopathology , Calcium Channel Blockers/therapeutic use , Nicardipine/therapeutic use , Quality of Life , Vertebral Artery/physiopathology , Aged , Calcium Channel Blockers/administration & dosage , Cohort Studies , Female , Humans , Male , Nicardipine/administration & dosage
10.
Rev Neurol ; 23(122): 819-25, 1995.
Article in Spanish | MEDLINE | ID: mdl-7497246

ABSTRACT

Knowing the epidemiology of migraine is important for a host of reasons. Migraine is one of the most prevalent types of headache. In addition, it constitutes a pathology which due to its cyclic, recurring and highly incapacitating characteristics has enormous repercussions on the quality of life of those affected; it is responsible for the loss of an important number of working days and of production; responsible too for the vast consumption of medicaments and consequently represents a considerable economic cost. An epidemiological study, however, of its pathology poses countless difficulties owing to its characteristics and its association with risk factors. In this present work we review the obstacles to carrying out migraine epidemiological studies and we also comment upon many such studies found in the literature. In each section we present the data obtained in such studies as were performed by our working group.


Subject(s)
Migraine Disorders/epidemiology , Adolescent , Adult , Aged , Child , Female , Humans , Incidence , Male , Middle Aged , Migraine Disorders/genetics , Prevalence , Risk Factors , Socioeconomic Factors
11.
Rev Neurol ; 23(122): 826-9, 1995.
Article in Spanish | MEDLINE | ID: mdl-7497247

ABSTRACT

Migraine is a paroxysmic abnormality in which asymtomatic periods alternate with the appearance of attacks. Such attacks are the end result of a chain of events leading on to the acute clinical syndrome. Amongst those phenomena which occur in the days prior to the attack starting, the factors which bring such attacks on have been widely studied by a great number of researchers. Identifying these initiating factors is a fundamental preventive element and looking into the behavioural mechanisms of such factors could prove useful in clarifying the pathogenic mechanisms of migraine. In the present study we review most of the works which have sought to identify these factors concerning the development of attacks and to work out their behavioural patterns.


Subject(s)
Migraine Disorders/physiopathology , Coffee/adverse effects , Eating , Ethanol/adverse effects , Exercise , Female , Humans , Menstrual Cycle , Migraine Disorders/etiology
12.
Rev Neurol ; 23(122): 830-2, 1995.
Article in Spanish | MEDLINE | ID: mdl-7497248

ABSTRACT

Stress is the precipitating factor in migraine which is most commonly recognized by patients. There are many affected who describe headaches brought on by stressful situations and events, although they also speak of the onset of their attacks during the period of calm immediately after such moments of stress. There are however few objective works in the literature which study the relationship between stress and migraine. In the present work we review that literature which does exist concerning such a relationship.


Subject(s)
Migraine Disorders/etiology , Stress, Psychological/psychology , Adult , Female , Humans , Hydrocortisone/blood , Middle Aged , Prolactin/blood , Thyrotropin/blood
15.
Neuroepidemiology ; 13(1-2): 34-9, 1994.
Article in English | MEDLINE | ID: mdl-8190204

ABSTRACT

A door-to-door survey of transient ischemic attack (TIA) and stroke was conducted in 3 towns of the Alcoi health area. The prevalence ratios found for TIA and stroke were 13/1,000 people (95% CI 8.8-17.9) and 21.5/1,000 (95% CI 15.8-27.2), respectively. The crude incidence rates for both TIA and stroke were 2.8/1,000 (95% CI 0.7-4.9). Methodological differences in the ascertainment of the cases may explain the variations in the rates between the present work and other studies in the literature.


Subject(s)
Cross-Cultural Comparison , Ischemic Attack, Transient/epidemiology , Adult , Aged , Aged, 80 and over , Cross-Sectional Studies , Female , Humans , Incidence , Ischemic Attack, Transient/diagnosis , Ischemic Attack, Transient/etiology , Male , Middle Aged , Neurologic Examination , Risk Factors , Spain/epidemiology
16.
Cephalalgia ; 12(6): 360-4, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1473138

ABSTRACT

We have investigated the autonomic function of 75 patients with migraine by examining cardiovascular reflex function. The results were compared with those of 78 healthy volunteers. Measurements were made between attacks. Patients with migraine showed a smaller heart-rate response to deep breathing but a greater heart-rate response and higher blood pressure to standing when compared to controls. Migraine patients had a higher percentage of established sympathetic lesions (51% vs 17%) and severe (25% vs 5%) or atypical (24% vs 11.5%) global autonomic dysfunction. No significant differences were found among patients with migraine with aura, migraine without aura, and migraine with prolonged aura. Our findings indicate that patients with migraine have sympathetic hypofunction.


Subject(s)
Cardiovascular System/physiopathology , Migraine Disorders/physiopathology , Reflex/physiology , Adolescent , Adult , Autonomic Nervous System/physiopathology , Blood Pressure/physiology , Chi-Square Distribution , Female , Heart Rate/physiology , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...